Neil Magno MSc BSc
Neil graduated from the University of Essex with a BSc (Hons) in Biochemistry, which included studying in Melbourne for one year at Monash University. Subsequently, he obtained his MSc (Distinction) in Cancer and Molecular & Cellular Biology at the Barts Cancer Institute (QMUL). His laboratory research project was focused on investigating the RAS-PI3K signalling pathway in non-small-cell lung carcinoma (NSCLC), particularly the role it plays in cancer-associated fibroblast contractility and extracellular matrix production.
Neil joined the KHP Cancer Biobank team at Guy’s Cancer Centre in March 2019 as a Biobank Technician. Amongst processing various cancer-related materials for the Biobank, Neil is involved in a benign bladder disease research programme, exploring the effect of botulinum toxin on the gene expression of several transmembrane receptors, ion channels and gap junctions. He is also deeply immersed in supporting and optimising a prospective longitudinal research pilot—the Cancer Microbiome Immunology Data Science (CABINDA) study. The initiative first aims to decipher the microbiota and immunological repertoire of patients diagnosed with advanced pancreatic ductal adenocarcinoma (PDAC)—and ultimately, reveal how it influences their response to treatment and disease progression.